About |
New York, New York, December 20, 2024 – Age Reversal Unity, a leading company dedicated to advancing research and policy on age-related health issues, is calling attention to the U.S. Food and Drug Administration’s (FDA) failure to respond to a citizen petition submitted on May 22, 2024, requesting that aging be officially classified as a disease. The FDA was required by law to respond within 180 days, but as of today, the agency has not issued a response.
The petition, submitted by Age Reversal Unity, advocates for the recognition of aging as a medical condition that could benefit from targeted research and treatments, opening the door to new scientific breakthroughs in age-related health. By officially recognizing aging as a disease, Age Reversal Unity argues that more resources, funding, and regulatory support could be directed toward the development of interventions that may improve quality of life for millions of aging Americans.
The FDA is mandated to respond to citizen petitions within 180 days of submission under the Federal Food, Drug, and Cosmetic Act. However, despite the significant scientific and societal implications of the petition’s request, the FDA has failed to meet this deadline. This delay has raised concerns among researchers, policymakers, and advocates within the aging and medical communities, who are now calling for immediate action.
“The FDA’s lack of response to this critical petition is a setback in the fight against age-related diseases and health disparities. Recognizing aging as a disease would empower researchers and innovators to develop solutions that could transform aging from an inevitability into a manageable condition,” said Age Reversal Unity. “We call on the FDA to fulfill its duty and respond to this petition without further delay. Millions of Americans suffer from age-related diseases that could be mitigated with proper research and treatment, and time is of the essence.”
Aging is the primary risk factor for many of the world’s most devastating diseases, including Alzheimer's, cardiovascular disease, and cancer. The failure to act on this petition is seen by Age Reversal Unity and other stakeholders as a missed opportunity to stimulate research that could lead to groundbreaking treatments for these conditions.
The petition also aims to address the growing public health burden of an aging population, emphasizing the need for preventive care and novel therapeutic approaches that go beyond merely managing symptoms. Classifying aging as a disease could potentially unlock new avenues for innovation and funding, ultimately improving the health and well-being of aging individuals.
“This is a critical moment in the fight for age-related health equality. We are at the precipice of a new era in aging science, and we need the FDA to step up and play its role,” said Age Reversal Unity.
Age Reversal Unity urges the FDA to act swiftly and respond to the petition, which has garnered support from numerous experts in the fields of gerontology, biology, and regenerative medicine. The company is committed to advocating for the recognition of aging as a disease and will continue to press for immediate action from the FDA.